Bayer / Elanco Bayrocin 150mg (Enrofloxacin) Broad-Spectrum Antibacterial Tablets for Dogs (Strip of 10 Tablets)

Select Variant: 1

Description

Effectively combat stubborn, deep-seated bacterial infections with Bayer / Elanco Bayrocin 150mg Tablets, available online at PetMitra. Bacterial infections in canines—ranging from recurrent cystitis and upper urinary tract infections to severe purulent pyoderma, infected bite wounds, secondary kennel cough pneumonia, and chronic otitis—require targeted, bactericidal intervention with high tissue bioavailability. Originally developed globally by Bayer Animal Health under the trade name Baytril and now manufactured and marketed by Elanco India, Bayrocin 150mg delivers rapid systemic antimicrobial clearance: Targeted DNA Gyrase Inhibition (Enrofloxacin 150 mg): Enrofloxacin belongs to the fluoroquinolone class developed specifically for veterinary medicine. It directly inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, essential enzymes required for bacterial chromosome replication, transcription, and repair. This produces rapid concentration-dependent bactericidal killing against susceptible pathogens. Broad-Spectrum Coverage: Highly active against serious gram-negative bacilli (such as Escherichia coli, Klebsiella, Proteus, Pseudomonas aeruginosa, Pasteurella) and effective against prominent gram-positive pathogens (Staphylococcus pseudintermedius). Exceptional Tissue & Urinary Penetration: Reaches therapeutic concentrations in difficult-to-penetrate tissues, including the urinary bladder and renal parenchyma, bronchial fluid, pulmonary macrophages, deep dermal tissues, prostate fluid, and bones. Rapid Oral Bioavailability: Well-absorbed through the canine digestive tract, delivering peak therapeutic blood levels within 1 to 2 hours of administration.